TETHER

Serial Number 98347552
688

Registration Progress

Application Filed
Jan 8, 2024
Under Examination
Nov 5, 2024
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jun 16, 2026 133 days

Trademark Image

TETHER

Basic Information

Serial Number
98347552
Filing Date
January 8, 2024
Published for Opposition
September 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Dec 16, 2025
Application
Pending
Classes
005 042

Rights Holder

Affini-T Therapeutics, Inc.

03
Address
100 Forge Road, Suite 900
Watertown, MA 02472

Ownership History

Affini-T Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Affini-T Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Theodore J. Bielen, Jr.

USPTO Deadlines

Next Deadline
133 days remaining
NOA E-Mailed - SOU Required
Due Date
June 16, 2026
Extension Available
Until December 16, 2026

Application History

16 events
Date Code Type Description Documents
Dec 16, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 7, 2025 NEWN I NEW NOA TO ISSUE Loading...
Nov 7, 2025 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Nov 4, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 6, 2025 PETG O PETITION TO REVIVE-GRANTED Loading...
May 6, 2025 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 10, 2024 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jul 10, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Apr 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 8, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of cancer identifying highly specific and potent T-cell receptors used against endogenously presented oncogenic driver peptides; Chemical reagents for medical purposes
Class 042
Medical and scientific research in the field of analysis and treatment of cancer utilizing T-cells

Classification

International Classes
005 042